Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Botulinum Toxin Type A for Neuroma Pain

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified December 2014 by Southern Illinois University
Sponsor:
Information provided by (Responsible Party):
Southern Illinois University
ClinicalTrials.gov Identifier:
NCT01374191
First received: June 13, 2011
Last updated: December 11, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)